Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001872873-26-000006

PRESIDENT AND CEO gave up 36,269 shares (to pay taxes)

  • PRESIDENT AND CEO acquired 120,095 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Option exercise +11,781 5,488,984 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Shares withheld for taxes −2,869 $4.67 $13,398 5,486,115 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Option exercise +22,100 5,508,215 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Shares withheld for taxes −5,382 $4.67 $25,134 5,502,833 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Option exercise +29,002 5,531,835 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Shares withheld for taxes −7,062 $4.67 $32,980 5,524,773 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Option exercise +57,212 5,581,985 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Shares withheld for taxes −20,956 $4.67 $97,865 5,561,029 D
Derivatives
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Option exercise · Restricted Stock Units −11,781 27,494 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Option exercise · Restricted Stock Units −22,100 139,973 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Option exercise · Restricted Stock Units −29,002 299,694 D
Jiang Wenbin PRESIDENT AND CEO 2026-08-18 Option exercise · Restricted Stock Units −57,212 820,054 D
Loading xslF345X06/form4-08202026_080812.xml…